Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Shareholders Equity (Details) - Schedule of Share Options and Their Weighted Average Exercise Price

v3.23.2
Shareholders Equity (Details) - Schedule of Share Options and Their Weighted Average Exercise Price
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Schedule of Share Options and Their Weighted Average Exercise Price [Abstract]  
Number of options, Beginning | shares 27,002,200
Weighted average exercise price, Beginning | $ / shares $ 0.13
Weighted average remaining contractual terms, Beginning 7 years 1 month 20 days
Aggregate intrinsic value, Beginning | $
Number of options, Grants | shares 15,500,000
Weighted average exercise price, Grants | $ / shares $ 0.01
Number of options, Forfeited/expired | shares (25,200)
Weighted average exercise price, Forfeited/expired | $ / shares $ 4.05
Number of options, Ending | shares 42,477,000
Weighted average exercise price, Ending | $ / shares $ 0.08
Weighted average remaining contractual terms, Ending 7 years 9 months 29 days
Aggregate intrinsic value, Ending | $
Number of options, Vested and expected to vest | shares 42,477,000
Weighted average exercise price, Vested and expected to vest | $ / shares $ 0.08
Weighted average remaining contractual terms, Vested and expected to vest 7 years 9 months 29 days
Aggregate intrinsic value, Vested and expected to vest | $
Number of options, Exercisable | shares 14,217,625
Weighted average exercise price, Exercisable | $ / shares $ 0.17
Weighted average remaining contractual terms, Exercisable 6 years 7 months 9 days
Aggregate intrinsic value, Exercisable | $